$1.52 0.03 (+2.01%)
11/25/2009 11:23 AM

AVI BioPharma, Inc. (AVII)

CAPS Rating: 4 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Featured Broker Partners